Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

Fig. 4

Biofunctions and mechanisms prediction of SYNJ2 in lung squamous cell carcinoma. A Selection of downregulated negatively co-expressed genes (Down-NCEGs) and upregulated positively co-expressed genes (Up-PCEGs). B Gene ontology analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis of Down-NCEGs. C Gene ontology analysis of Up-PCEGs. D KEGG analysis of Up-PCEGs. E The relationship between SYNJ2 expression and infiltration levels of immune cells; the blue “violin” refers to the low-SYNJ2 expression group, while the red “violin” refers to the high-SYNJ2 expression group

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us